<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/79</identifier>
				<datestamp>2021-08-30T21:16:10Z</datestamp>
				<setSpec>bovine:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Clinical efficacy of gamithromycin versus florfenicol for the treatment of undifferentiated fever in winter-placed feedlot calves</dc:title>
	<dc:creator xml:lang="en">Van Donkersgoed, Joyce</dc:creator>
	<dc:creator xml:lang="en">Hendrick, Steve</dc:creator>
	<dc:subject xml:lang="en">bovine</dc:subject>
	<dc:subject xml:lang="en">BRD</dc:subject>
	<dc:subject xml:lang="en">undifferentiated fever</dc:subject>
	<dc:subject xml:lang="en">gamithromycin</dc:subject>
	<dc:subject xml:lang="en">florfenicol</dc:subject>
	<dc:subject xml:lang="en">calves</dc:subject>
	<dc:subject xml:lang="en">cost benefit analysis</dc:subject>
	<dc:subject xml:lang="en">efficacy</dc:subject>
	<dc:subject xml:lang="en">feedlots</dc:subject>
	<dc:subject xml:lang="en">respiratory diseases</dc:subject>
	<dc:description xml:lang="en">A study was conducted in Alberta, Canada utilizing 4 commercial feedlots to compare the clinical efficacy of gamithromycin to florfenicol for the initial treatment of undifferentiated fever (UF) in winter-placed feedlot calves. There were no significant differences (P&amp;gt;0.05) in UF relapse rates and crude case fatality or bovine respiratory disease/histophilus fatality rates between the 2 treatment groups. As a result, the cost-benefit of gamithromycin versus florfenicol was based on the difference in treatment cost between the 2 drugs. Using current market prices and a treatment weight of 750 lb (340 kg), gamithromycin had an economic advantage of $11.52 CAN per head over florfenicol.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>2013-06-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/bovine/article/view/79</dc:identifier>
	<dc:identifier>10.21423/bovine-vol47no2p152-158</dc:identifier>
	<dc:source xml:lang="en">The Bovine Practitioner; Vol. 47, No. 2 (2013 Summer); 152-158</dc:source>
	<dc:source>0524-1685</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/bovine/article/view/79/7634</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2013 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
